There are different theories about the coexistence of EGFR mutations and ALK rearrangement in NSCLC—the two gene alterations coexist in different areas (i.e., different cells) of the tumor (111) or are present in the same tumor cells (112). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.